Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.83
-0.27 (-4.43%)
Jan 28, 2026, 11:04 AM EST - Market open
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $320.06 million as of January 28, 2026. Its market cap has decreased by -13.69% in one year.
Market Cap
320.06M
Enterprise Value
255.12M
1-Year Change
-13.69%
Ranking
Category
Stock Price
$5.83
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $320.06M, an increase of 43.92%. That is a compound annual growth rate of 8.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 329.94M | 6.37% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 349.76M |
| Foghorn Therapeutics | 345.63M |
| Allogene Therapeutics | 343.84M |
| Immuneering | 337.70M |
| Aldeyra Therapeutics | 333.30M |
| Puma Biotechnology | 331.07M |
| Fractyl Health | 325.15M |
| Rezolute | 324.55M |